A b s t r a c t e activity of β-lactam antibiotics (oxacillin, cloxacillin, cephalotin), vancomycin, gentamicin and rifampicin applied in vitro individually and in combination against 37 nosocomial methicillin-resistant strains of coagulase-negative staphylococci (CNS) was assessed to demonstrate the heterogeneity of this group of bacteria and estimate the chance of the efficacy of such therapy. e strains belonged to four species: Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus cohnii, Staphylococcus hominis. ey originated from a hospital environment and from the skin of medical sta of the intensive care unit of a paediatric ward at a university hospital. All strains were methicillin-resistant, according to CLSI standards, but individual strains di ered in MIC OX values. Susceptibility to other tested antibiotics was also characteristic for the species. e increased susceptibility to antibiotics in combinations, tested by calculating the fractional inhibitory concentration (FIC) index, concerned 26 out of 37 investigated strains and it was a feature of a particular species. Combinations of vancomycin and cephalotin against S. epidermidis and oxacillin with vancomycin were significant, as well as cephalotin and rifampicin in growth inhibition of multiresistant S. haemolyticus strains.
Introduction
Coagulase-negative staphylococci (CNS) have been regarded as a threat since the 80s of the last century due to advances in medicine and implementation of new medical methods. is type of infection is difficult to diagnose as it is o en not easy to distinguish an etiological disease factor from a natural ora contamination. Recently, much more attention has been paid to the need of CNS species identification and searching for a connection between species affiliation and the clinical importance of particular staphylococci (Tan et al., 2006; Hamels et al., 2001) .
CNS are the leading causes of nosocomial bloodstream infections (Chandran and Rennie, 2005; Frigatto et al., 2005) . According to Finkelstein et al., (2002) morbidity among patients with CNS bacteriemia amounts to 16%, hence investigations concerning di erences in resistance profiles of particular species of this group, especially multi-resistant strains are of particular significance. e increase of bacterial resistance forces rational antibiotic therapy in order to maintain the efficacy of these drugs for as long as possible (Wang and Lipstich, 2006) . Methods of alternative therapy against these infections are being sought. One of them can be combination therapy (Dawis et al., 2003; Guerrero and Gorgolas, 2006; Miranda-Nowales et al., 2006) .
In the presented investigations, the activity of β-lactam antibiotics (oxacillin, cloxacillin, cephalotin), vancomycin, gentamicin and rifampicin applied in vitro as single or in combination against nosocomial methicillin-resistant CNS belonging to S. epidermidis, S. haemolyticus, S. cohnii and S. hominis was investigated.
Experimental

Materials and Methods
37 methicillin-resistant CNS from our own collection were tested. ey belonged to S. epidermidis (n = 12), S. haemolyticus (n = 9), S. cohnii (n = 10), S. hominis (n = 6). e strains originated from hospital environment and from the skin of medical sta of the intensive care unit at a paediatric ward of a university hospital. Identification to the species level was performed with API-Staph System (BioMérieux). Only a single isolate per patient was tested. Methicillin resistance was detected phenotypically with a cefoxitin test (FOX 30 -Becton-Dickinson) and confirmed by mecA gene detection in PCR method (PK14 kit -DNAGdańskII) (Van Griethuysen et al., 1999) . β-lactamase was detected in a cefinase test (Becton-Dickinson). Strains were stored frozen in glycerol-broth at the temperature of -70°C.
Strain susceptibility tests were performed according to the standards of the CLSI (2008) (Climo et al., 1999; Dawis et al., 2003) . All tests were performed at least twice. Reference strains were S. aureus ATCC 29213 and ATCC 25923. Quantitative variables were calculated using the Kruskal-Wallis test.
Results
All investigated strains were methicillin-resistant according to CLSI standards but individual strains presented di erent levels of oxacillin susceptibility, expressed in MIC OX values (Table I ). e greatest number of strains with low MIC (≤4 mg/l) was found among S. hominis, with an average MIC (8-128 mg/l) among S. epiderminis and with high MIC (≥256 mg/l) among S. cohnii.
ere were significant di erences in MIC values (from 0.5 to 2048 mg/l) within species, particularly in S. haemolyticus. Nevertheless, the di erences in antibiotic-resistance between species were clearly visible and statistically important in the Kruskal-Wallis test.
Ranges of MIC values for the tested antibiotics: cloxacillin, cephalotin, gentamicin, vancomycin and rifampicin were also di erent for individual species (Fig. 1 ). Resistant strains with high MIC values were the most numerous among S. haemolyticus. In spite of great standard deviations, it can be stated that statistically significant di erences among species in their sensitivity to particular antibiotics not only concerned di erences in absolute MIC values, but also sensitivity or resistance in the clinical sense, thus placing above or below the breakpoint values for individual antibiotics.
Using UPGMA (unweighted pair group mathematical averages), a dendrogram was created. e dendrogram grouped all investigated strains in relation to their antibiotic-susceptibility and the level of their resistance was expressed in MIC values. Strains formed several clusters and particular species were located in separated areas on the axis. S. haemolyticus strains were located mostly on the le side, S. epidermidis on the right, whereas S. cohnii and S. hominis in the central part of the dendrogram (Fig. 2) .
In further experiments, the activity of antibiotics in combination was tested. Disc-di usion method allowed to observe the occurrence of synergism between cephalotin and vancomycin (CF+VA), cephalotin and rifampicin (CF+RA), oxacillin and vancomycin (OX+VA), cephalotin and cloxacillin (CF+CX). In none of the investigated combinations either antagonism or addition occurred. For the strains in which, on the basis of growth inhibition zone shape around discs, the beneficial activity of antibiotics used in combination was observed, FIC index was calculated confirming or excluding synergism. Synergistic action was confirmed in most cases. It concerned 26 out of 37 investigated strains (Fig. 3) . Most susceptible strains were among S. epidermidis -10 out of 12 of the tested ones. e S. epidermidis (12) 1-256 5 (42%) 6 (50%) 1 (8%)
S. haemolyticus (9) 0.5-2048 4 (45%) 2 (22%) 3 (33%)
S. cohnii (10) 4-512 1 (10%) 3 (30%) 6 (60%)
S. hominis (6) 0.5-64 5 (83%) 1 (17%) 0 majority of them reacted this way to two or three pairs of antibiotics. Mostly, it was the combination of CF+VA. e same e ect was achieved for most of the strains by CF+RA binding. Only for S. epidermidis CF+CX combination synergism occurred. However, for none of the S. epidermidis strains, synergism of β-lactams and gentamicin was determined. Synergistic activity of antibiotics against S. haemolyticus was observed for six out of nine tested strains. Mostly, combination of OX+VA (5 strains) presented synergism, less frequently combination of CF+RA (3 strains). Synergistic activity in eight out of ten of the tested S. cohnii strains presented CF+RA and in half of the tested strains a combination of CF+GM occurred. In S. hominis synergism was noticed only against two strains and only for one pair of antibiotics (CF+ GM). Sensitivity to particular pairs of antibiotics was a feature connected with species. e combination presenting a synergistic e ect in relation to the greatest number of tested strains was CF+RA. is combination was e ective when MIC of In the case of vancomycin and rifampicin, breakpoints were higher than the maximum points on a chart scale.
cephalotin as a single antibiotic was ≤8 µg/ml (sensitive strain) but also when it was ≥32, µg/ml (resistant strain). Production of β-lactamases was a feature characteristic for almost all strains of the three tested species. e exception was S. cohnii strains, the majority of which did not produce β-lactamases. ere was no connection between synergism occurrence and production of those enzymes.
Strains presenting a synergistic reaction to the highest number of antibiotics combinations are shown in Fig. 2 . Dendrogram presenting similarity in susceptibility to 6 antibiotics of 37 strains belonging to four tested species. e use of combinations of antibiotics gave an e ective growth inhibition of the tested bacteria with simultaneously lowered antibiotic concentration. For S. epidermidis strains vancomycin concentration could be lowered 8-64 fold and for S. haemolyticus and S. cohnii 4-fold. Cephalotin could be applied mostly in the dose of 4-16 times lower than when it was applied individually.
Discussion
CNS include several dozens of species and are a heterogenic group of microorganisms, but only some of them are frequently isolated from humans. ere is no doubt nowadays that these bacteria, especially methicillin-resistant strains, are important nosocomial pathogens. In this research strains belonging to four of these species were investigated. ree of those are species considered the most important in hospital infections (S. epidermidis, S. haemolyticus, S. hominis), relatively o en isolated from clinical samples (Kloos and Bannerman, 1994; Weinstein et al., 1998) and numerously represented in the hospital environment. S. cohnii strains are less frequent in clinical materials, but o en occur in the hospital environment and on the skin of medical personnel. S. hominis may be considered a resistance reservoir in the environment (Kloos, 1997; Szewczyk et al., 2004) . All strains were multiresistant and it could be assumed that this resistance was a result of selective pressure. Potentially, each of them could become the cause of a hospital infection. e need to identify CNS species, wrongly treated as the same, is o en perceived. It is stressed by many authors that such approach is a significant obstacle in research and diagnostics (Tacconelli et al., 2003) . Nevertheless, there are still papers, even quite recent ones, in which all isolates from this group are treated equally (Kuti et al., 2008) . ere were also some radical opinions questioning antibiotic resistance evaluation of microorganisms from this group (Chandran and Rennie, 2005) . is work was to defy such approach by showing the results of our research. Methicillin resistance estimation of CNS still rises doubts and discussion. is stems from the di erences among particular species.
e di erences between novobiocin-sensitive and novobiocin-resistant species are clearly visible, however, the similarity of S. haemolyticus to the latter group is noticeable (Nowak et al., 2006; Frigatto et al., 2005) . is is presumably connected with the content of di erent cassettes including mecA gene in staphylococci (Martins and Maria de Lourdes Cunha, 2007) and perhaps also with other features of these bacteria. ere is an urgent need for research in this matter.
e multiresistant strains tested herein clearly show the di erences in antibiotic susceptibility profiles of the tested species. It may be suspected that they also di er in genetic equipment. e results showed the noticeable resistance of strains of S. haemolyticus and S. cohnii. John et al., 2002 , who conducted a research on the spectrum of 658 clinical staphylococcal isolates belonging to 13 species, pointed out that the highest levels of participation of isolates resistant to oxacyllin, erythromycin, klindamycin and telithromycin were presented by S. haemolyticus and S. epidermidis while for S. cohnii to quinupristin/dalfopristin. e presence of multiple plasmids in the cells was shown in the latter species (Szewczyk et al., 2004) .
Sensitivity to cephalosporins maintained in methicillin-resistant staphylococci strains (S. epidermidis, S. hominis) was observed previously. In the research of Krediet et al., (1999) this feature was characteristic for 25 (almost 70%) of the tested strains including all from S. epidermidis and S. hominis, five strains of S. haemolyticus and two of S. cohnii. e use of this antibiotic in CNS infection therapy should be analysed thoroughly, particularly because of earlier suggestions to apply it. All environmental strains of staphylococci tested by Szewczyk et al., (2000) were susceptible to cefuroxime and cefotaxime. 87% and 71% isolates from infants were respectively susceptible to two of these cephalosporins. All investigated strains of S. epidermidis from both groups were susceptible to cephalotin.
All of the strains from the collection tested in this research were sensitive to vancomycin and rifampicin, though clear di erences in MIC values among species were visible (Fig. 1) . Vancomycin is still frequently used in treatment of serious infections caused by gram-positive microorganisms, but stepping away from vancomycin therapy and replacing it with, e.g. cloxacillin both in cases of infections caused by S. aureus and CNS is recommended (Lawrence et al., 2005) . As can be seen in the results presented in this work, therapy with cloxacillin would not meet the expectations in case of all species investigated CNS except S. haemolyticus, especially in combination with cephalotin. Lowered sensitivity to glycopeptides of S. aureus and S. epidermidis strains was described by authors who analysed CNS clinical isolates' sensitivity to vancomycin and claimed appearance of tolerance to that antibiotic and low sensitivity level (Walsh et al., 2001; Bourgeois et al., 2007) .
Several studies have previously reported the synergistic e ect of antibiotics on methicillin-resistant strains of staphylococci. Such studies have been undertaken mostly towards infections caused by multiresistant clinical strains i.e. MRSA (Dawis et al., 2003) . Also research on treatment of infections with those bacteria in experimental models has been carried out. Fox et al. (2006) , showed that using nafcillin and vancomycin in combination cleared bloodstream infections in experimental endocarditis in rabbit models caused by vancomycin-resistant S. aureus. Efficacy of treatment with vancomycin in combination with aminoglysides against MRSA has also been tested (Lee et al., 2003) . In the study of Miranda-Nowales (2006) , synergy was evident for dicloxacillin or cephalotin in combination with amikacin against methicillin-resistant Staphylococcus spp.
In this research it has been shown that there is a chance to obtain an efficient antibiotic therapy in combination also in infections caused by CNS. Combinations of vancomycin and cephalotin against S. epidermidis, staphylococcus most frequently isolated from gram-positive hospital infections, seem to be particularly promising. A synergistic e ect on growth inhibition of multiresistant S. haemolyticus strains was obtained using oxacillin and vancomycin as well as cephalotin and rifampicin. However, clinical research including species identification of CNS causing infections is necessary, because as can be seen, individual species of this group di er in antibiotic resistance.
